Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Csehország

In Csehország 10 Also abroad 559

10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
Where
Havlickuv Brod, Kralupy nad Vltavou, Liberec I-Stare Mesto, Miroslav, Prague, Varnsdorf
Életkor
40 év to 80 év
People
402 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT07725939 · EU 2026-525523-25-00
2. fázisTaking people
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Where
Jindrichuv Hradec III, Miroslav, Moravska Ostrava A Privoz, Prague
Életkor
40 év to 75 év
People
606 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00
3. fázisTaking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Where
Brandýs nad Labem-Stará Boleslav, Havlíčkův Brod, Hradec Králové, Jindřichův Hradec, Kralupy nad Vltavou, Prague
Életkor
40 év to 80 év
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00
2/3. fázisTaking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Where
Brandýs nad Labem-Stará Boleslav, Jindrichuv Hradec III, Mladá Boleslav, Prague, Prague 4, Varnsdorf
Életkor
35 év to 80 év
People
1156 worldwide
Run by
Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00
2. fázisNot yet taking people in Csehország
A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
Where
Brno, Jindrichuv Hradec III, Kralupy nad Vltavou, Miroslav, Mladá Boleslav, Tábor
Életkor
18 év and over
People
183 worldwide
Run by
Expedition Therapeutics Inc.
See details and how to join2026-525216-34-00 · EU 2026-525216-34-00
3. fázisTaking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Where
Jindrichuv Hradec III, Nymburk, Prague, Varnsdorf
Életkor
40 év to 80 év
People
961 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00
3. fázisTaking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Brandýs nad Labem, Jindrichuv Hradec III, Kralupy nad Vltavou, Moravska Ostrava A Privoz, Olomouc, Prague 1, Prague 4, Rokycany, Tábor
Életkor
40 év to 80 év
People
5250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00
3. fázisTaking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Where
Brno, Jindrichuv Hradec III, Lovosice, Plzen 3, Prague, Teplice, Varnsdorf
Életkor
40 év to 80 év
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00
2. fázisTaking people
Psilocybin Therapy for Psychological Distress in Palliative Patients
Where
Klecany
Életkor
18 év and over
People
108 worldwide
Run by
University Medical Center Groningen
See details and how to joinNCT06782724 · EU 2023-510488-36-01
No phaseTaking people
Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma
Where
Hradec Králové
Életkor
18 év and over
People
1000
Run by
Charles University, Czech Republic
See details and how to joinNCT07183657